[The ideal dosage form for clinical study. Bosentan in pediatric patients]

Pharm Unserer Zeit. 2010 Nov;39(6):454-8. doi: 10.1002/pauz.201000391.
[Article in German]
No abstract available

Publication types

  • Review

MeSH terms

  • Aging / physiology
  • Antihypertensive Agents / administration & dosage*
  • Antihypertensive Agents / pharmacokinetics
  • Antihypertensive Agents / therapeutic use*
  • Bosentan
  • Chemistry, Pharmaceutical
  • Child
  • Dosage Forms
  • Humans
  • Hypertension, Pulmonary / drug therapy*
  • Sulfonamides / administration & dosage*
  • Sulfonamides / pharmacokinetics
  • Sulfonamides / therapeutic use*

Substances

  • Antihypertensive Agents
  • Dosage Forms
  • Sulfonamides
  • Bosentan